Singh; Sheo B.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Singh; Sheo B..The latest application filed is for "use of the antifungal ilicicolin h in agriculture".
- Singh; Sheo B. - Edison NJ
- Singh; Sheo B. - Tempe AZ
| Patent | Date |
|---|---|
| Use of the Antifungal Ilicicolin H in Agriculture App 20190335751 - Polishook; Jon D. ; et al. | 2019-11-07 |
| Use of the antifungal ilicicolin H in agriculture Grant 10,412,965 - Polishook , et al. Sept | 2019-09-17 |
| Nargenicin compounds and uses thereof as antibacterial agents Grant 10,144,741 - Young , et al. De | 2018-12-04 |
| Use Of The Antifungal Ilicicolin H In Agriculture App 20180271092 - Polishook; Jon D. ; et al. | 2018-09-27 |
| Nargenicin Compounds And Uses Thereof As Antibacterial Agents App 20180186808 - Young; Katherine ; et al. | 2018-07-05 |
| Nargenicin compounds and uses thereof as antibacterial agents Grant 9,944,654 - Young , et al. April 17, 2 | 2018-04-17 |
| Nargenicin Compounds And Uses Thereof As Antibacterial Agents App 20170305924 - Young; Katherine ; et al. | 2017-10-26 |
| Bridged Bicyclic Compounds For The Treatment Of Bacterial Infections App 20140243302 - Fukuda; Yasumichi ; et al. | 2014-08-28 |
| Method of treatment using fatty acid synthesis inhibitors Grant 8,598,153 - Singh , et al. December 3, 2 | 2013-12-03 |
| Method Of Treatment Using Fatty Acid Synthesis Inhibitors App 20120190747 - Singh; Sheo B. ; et al. | 2012-07-26 |
| Method of treatment using fatty acid synthesis inhibitors Grant 8,173,629 - Singh , et al. May 8, 2 | 2012-05-08 |
| Antibiotic compound Grant 7,807,445 - Basilio , et al. October 5, 2 | 2010-10-05 |
| Antibiotic Compound App 20100144879 - Basilio; Angela ; et al. | 2010-06-10 |
| Method of treatment using fatty acid synthesis inhibitors App 20100022630 - Singh; Sheo B. ; et al. | 2010-01-28 |
| Inhibitors of farnesyl-protein transferase Grant 5,663,193 - Cascales , et al. September 2, 1 | 1997-09-02 |
| Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" Grant 5,569,786 - Pettit , et al. October 29, 1 | 1996-10-29 |
| Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" Grant 5,409,953 - Pettit , et al. April 25, 1 | 1995-04-25 |
| Process for the production of a novel endothelin antagonist Grant 5,352,800 - Bills , et al. October 4, 1 | 1994-10-04 |
| Inhibitors of farnesyl protein transferase Grant 5,260,479 - Singh * November 9, 1 | 1993-11-09 |
| Inhibitors of farnesyl protein transferase Grant 5,260,465 - Singh , et al. November 9, 1 | 1993-11-09 |
| Inhibitors of farnesyl protein transferase Grant 5,245,061 - Singh September 14, 1 | 1993-09-14 |
| Combretastatin A-4 Grant 4,996,237 - Pettit , et al. February 26, 1 | 1991-02-26 |
| Synthesis of dolastatin 10 Grant 4,978,744 - Pettit , et al. December 18, 1 | 1990-12-18 |
| Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2 Grant 4,940,726 - Pettit , et al. July 10, 1 | 1990-07-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 